Funds holding PELTHOS THERAPEUTICS INC
ISIN US1711262048 · United States
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- 2.2M $
- Share of capital
- 2.7 % of 3.8M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 78,008 | 1.6M $ | 0.00 % | 2.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 12,996 | 273K $ | 0.00 % | 0.34 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 7,057 | 186K $ | 0.00 % | 0.18 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 2,089 | 43.9K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,052 | 54.1K $ | 0.05 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,726 | 45.5K $ | 0.05 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 6 | 0 | 103,928 | +37.1 % |
| 2026Q1 | 6 | +1 | 75,830 | +20.7 % |
| 2025Q4 | 5 | 62,838 |
Institutional managers
15 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Murchinson Ltd. | 296,314 | 6.2M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 256,598 | 5.4M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 81,858 | 1.7M $ | as of Mar 31, 2026 |
| J. Goldman & Co LP | 50,415 | 1.1M $ | as of Mar 31, 2026 |
| CANTOR FITZGERALD, L. P. | 41,423 | 870.3K $ | as of Mar 31, 2026 |
| DIADEMA PARTNERS LP | 24,773 | 520.5K $ | as of Mar 31, 2026 |
| Knott David M Jr | 21,073 | 442.7K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 15,290 | 321.2K $ | as of Mar 31, 2026 |
| Pale Fire Capital SE | 12,919 | 271.4K $ | as of Mar 31, 2026 |
| Persistent Asset Partners Ltd | 6,007 | 126.2K $ | as of Mar 31, 2026 |
| Steward Partners Investment Advisory, LLC | 1,910 | 40.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 764 | 16.1K $ | as of Mar 31, 2026 |
| Farther Finance Advisors, LLC | 40 | 852 $ | as of Mar 31, 2026 |
| Aspect Partners, LLC | 16 | 336 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 21 $ | as of Mar 31, 2026 |
Declared shareholders of PELTHOS THERAPEUTICS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| 3i, LP and 2 others | 9.90 % | 337,026 | as of Mar 31, 2026 · SCHEDULE 13G |
| Ikarian Capital, LLC and 1 other | 7.70 % | 256,598 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding PELTHOS THERAPEUTICS INC". https://titelia.com/en/stocks/pelthos-therapeutics-inc-US1711262048